Details for New Drug Application (NDA): 211706
NDA 211706 describes MOMETASONE FUROATE, which is a drug marketed by Chartwell Molecular, Cosette Pharms Nc, Fougera Pharms, Glenmark Pharms, Sun Pharma Canada, Encube, Glenmark Pharms Ltd, Padagis Israel, Padagis Us, Torrent, Amneal, Amneal Pharms, Apotex, Aurobindo Pharma, and Naspress, and is included in twenty-five NDAs. It is available from sixteen suppliers. Additional details are available on the MOMETASONE FUROATE profile page.
The generic ingredient in MOMETASONE FUROATE is mometasone furoate. There is one drug master file entry for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
The generic ingredient in MOMETASONE FUROATE is mometasone furoate. There is one drug master file entry for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Summary for 211706
| Tradename: | MOMETASONE FUROATE |
| Applicant: | Naspress |
| Ingredient: | mometasone furoate |
| Patents: | 0 |
Pharmacology for NDA: 211706
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 211706
Suppliers and Packaging for NDA: 211706
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MOMETASONE FUROATE | mometasone furoate | SPRAY, METERED;NASAL | 211706 | ANDA | Slate Run Pharmaceuticals, LLC. | 70436-154 | 70436-154-21 | 1 BOTTLE, PUMP in 1 CARTON (70436-154-21) / 120 SPRAY, METERED in 1 BOTTLE, PUMP |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY, METERED;NASAL | Strength | 0.05MG/SPRAY | ||||
| Approval Date: | May 15, 2025 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
